Neuheit Pharma Private Limited, a dissolved under section 59(8) private limited company, was established on 16 March 2015 in Kukatpally, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233TG2015PTC098047. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹24.10 Cr and a paid-up capital of ₹23.10 Cr.
It upholds a compliant status. Employing 36 professional, Its leadership includes Patrick Mark Dentinger (Director), Siddhartha Bhoopathy (Director), Venkateswarlu Vobalaboina (Director). Past directors included Rafeeq Mohammed. It holds no open charges and ₹12.50 Cr settled loans. Its latest AGM occurred on 02 December 2020, with the balance sheet filed on 31 March 2020. It is based at Plotno 43&44,Aleapindustrial Estate,Gajularamaram, Nearpragthinagar,Opp:Jntu Universtiy,Kuk, Atpally, Kukatpally, Telangana, 500072.
U24233TG2015PTC098047
098047
16 March 2015
₹24.10 Cr
₹23.10 Cr
Roc Hyderabad
Unlisted
Dissolved Under Section 59(8)
Explore comprehensive insights into Neuheit Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Patrick Mark Dentinger | Director | 10 Aug 2017 | Current |
| Siddhartha Bhoopathy | Director | 10 Aug 2017 | Current |
| Venkateswarlu Vobalaboina | Director | 16 Mar 2015 | Current |
| Srinivas Irukulla | Managing Director | 16 Mar 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Neuheit Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 935.28% increase. The company also saw a substantial fall in profitability, with a 18020.04% decrease in profit. The company's net worth observed a substantial decline by a decrease of 31.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Neuheit Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹125,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Nov 2018 | Others | ₹12.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Neuheit Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Neuheit Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuheit Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 22 Nov 2018 via Charge ID 100223621 with Others was fully satisfied on 15 Jan 2021. was documented.
Progress on Neuheit Pharma Private Limited last Annual general meeting of members was held on 02 Dec 2020 as per latest MCA records. was documented.
Neuheit Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad. was recorded as a recent event.
A charge with Others amounted to Rs. 12.50 Cr with Charge ID 100223621 was registered on 22 Nov 2018. was recorded as a recent event.
Patrick Mark Dentinger was appointed as a Director was appointed as a Director on 10 Aug 2017 & has been associated with this company since 8 years 3 months . was recorded as a recent event.
The activity Siddhartha Bhoopathy was appointed as a Director was appointed as a Director on 10 Aug 2017 & has been associated with this company since 8 years 3 months . was completed.
The CIN of Neuheit Pharma Private Limited is U24233TG2015PTC098047.
Neuheit Pharma Private Limited is headquartered at Plotno 43&44,Aleapindustrial Estate,Gajularamaram, Nearpragthinagar,Opp:Jntu Universtiy,Kuk, Atpally, Kukatpally, Telangana, 500072.
Neuheit Pharma Private Limited was incorporated on 16 March 2015.
The current directors of Neuheit Pharma Private Limited are
The primary industry of Neuheit Pharma Private Limited is Manufacturing.
Neuheit Pharma Private Limited is unlisted.
The authorized capital of Neuheit Pharma Private Limited is ₹24.10 Cr, and the paid-up capital is ₹23.10 Cr.
The compliance status of Neuheit Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX